{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:20:41Z","timestamp":1791382841493,"version":"4.3.3"},"reference-count":285,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Chronic kidney disease (CKD) is a global public health issue characterized by progressive loss of kidney function, of which end-stage kidney disease (ESKD) is the last stage. The global increase in the prevalence of CKD is linked to the increasing prevalence of traditional risk factors, including obesity, hypertension, and diabetes mellitus, as well as metabolic factors, particularly insulin resistance, dyslipidemia, and hyperuricemia. Mortality and comorbidities, such as cardiovascular complications, rise steadily as kidney function deteriorates. Patients who progress to ESKD require long-term kidney replacement therapy, such as transplantation or hemodialysis\/peritoneal dialysis. It is currently understood that a crucial aspect of CKD involves persistent, low-grade inflammation. In addition, increased oxidative and metabolic stress, endothelial dysfunction, vascular calcification from poor calcium and phosphate metabolism, and difficulties with coagulation are some of the complex molecular pathways underlying CKD-related and ESKD-related issues. Novel mechanisms, such as microbiome dysbiosis and apolipoprotein L1 gene mutation, have improved our understanding of kidney disease mechanisms. High kidney disease risk of Africa has been linked to APOL1 high-risk alleles. The 3-fold increased risk of ESKD in African Americans compared to European Americans is currently mainly attributed to variants in the APOL1 gene in the chromosome 22q12 locus. Additionally, the role of new therapies such as SGLT2 inhibitors, mineralocorticoid receptor antagonists, and APOL1 channel function inhibitors offers new therapeutic targets in slowing down the progression of chronic kidney disease. This review describes recent molecular mechanisms underlying CKD and emerging therapeutic targets.<\/jats:p>","DOI":"10.3389\/fmed.2025.1526090","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T01:58:30Z","timestamp":1739498310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Advances in kidney disease: pathogenesis and therapeutic targets"],"prefix":"10.3389","volume":"12","author":[{"given":"Vincent","family":"Boima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Baafi","family":"Agyekum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushali","family":"Ganatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Agyekum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kwakyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil","family":"Inusah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer Nayra","family":"Ametefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwomoa","family":"Adu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/ndt\/gfv254","article-title":"New insights in molecular mechanisms involved in chronic kidney disease using high-resolution plasma proteome analysis","volume":"30","author":"Glorieux","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/biomedicines11113033","article-title":"An overview of chronic kidney disease pathophysiology: the impact of Gut Dysbiosis and Oral disease","volume":"11","author":"Altamura","year":"2023","journal-title":"Biomedicines"},{"key":"ref3","author":"Arora","year":"2021"},{"key":"ref4","first-page":"2","article-title":"1. Pathophysiology and classification of kidney diseases","volume":"20","author":"Matovinovi\u0107","year":"2009","journal-title":"EJIFCC"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"645187","DOI":"10.3389\/fmed.2021.645187","article-title":"Therapeutic insights in chronic kidney disease progression","volume":"8","author":"Shabaka","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"103466","DOI":"10.1016\/j.drudis.2022.103466","article-title":"Promising novel therapeutic targets for kidney disease: emphasis on kidney-specific proteins","volume":"28","author":"Tejeswini Sen","year":"2023","journal-title":"Drug Discov Today"},{"key":"ref7","article-title":"Chronic kidney disease","volume-title":"StatPearls","author":"Vaidya","year":"2024"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/biomedicines10112846","article-title":"New insights into molecular mechanisms of chronic kidney disease","volume":"10","author":"Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2215\/CJN.09990819","article-title":"Systems biology and kidney disease","volume":"15","author":"Schaub","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"146A","DOI":"10.1021\/es022253t","article-title":"Peer reviewed: perfluorochemical surfactants in the environment","volume":"36","author":"Giesy","year":"2002","journal-title":"Environ Sci Technol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00420-006-0136-1","article-title":"Occurrence of perfluorinated substances in an adult German population in southern Bavaria","volume":"80","author":"Fromme","year":"2007","journal-title":"Int Arch Occup Environ Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/toxsci\/kfm128","article-title":"Perfluoroalkyl acids: a review of monitoring and toxicological findings","volume":"99","author":"Lau","year":"2007","journal-title":"Toxicol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"144107","DOI":"10.1016\/j.scitotenv.2020.144107","article-title":"An evaluation of health-based federal and state PFOA drinking water guidelines in the United States","volume":"761","author":"Garnick","year":"2021","journal-title":"Sci Total Environ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13280-016-0848-8","article-title":"A review of contamination of surface-, ground-, and drinking water in Sweden by perfluoroalkyl and polyfluoroalkyl substances (PFASs)","volume":"46","author":"Banzhaf","year":"2017","journal-title":"Ambio"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41370-018-0099-9","article-title":"Guideline levels for PFOA and PFOS in drinking water: the role of scientific uncertainty, risk assessment decisions, and social factors","volume":"29","author":"Cordner","year":"2019","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.envint.2017.06.007","article-title":"Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community","volume":"106","author":"Worley","year":"2017","journal-title":"Environ Int"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"77004","DOI":"10.1289\/EHP6785","article-title":"Serum half-lives for short- and Long-chain Perfluoroalkyl acids after ceasing exposure from drinking water contaminated by firefighting foam","volume":"128","author":"Xu","year":"2020","journal-title":"Environ Health Perspect"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"106333","DOI":"10.1016\/j.envint.2020.106333","article-title":"Serum perfluoroalkyl substances in residents following long-term drinking water contamination from firefighting foam in Ronneby, Sweden","volume":"147","author":"Xu","year":"2021","journal-title":"Environ Int"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"107198","DOI":"10.1016\/j.envint.2022.107198","article-title":"Determinants of serum half-lives for linear and branched perfluoroalkyl substances after long-term high exposure-a study in Ronneby, Sweden","volume":"163","author":"Li","year":"2022","journal-title":"Environ Int"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/toxsci\/kfp055","article-title":"Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin","volume":"109","author":"Weiss","year":"2009","journal-title":"Toxicol Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yrtph.2010.12.004","article-title":"Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model","volume":"59","author":"Loccisano","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1897\/02-553","article-title":"Binding of perfluorinated fatty acids to serum proteins","volume":"22","author":"Jones","year":"2003","journal-title":"Environ Toxicol Chem"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0009-2797(92)90003-4","article-title":"Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats","volume":"82","author":"Vanden Heuvel","year":"1992","journal-title":"Chem Biol Interact"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.scitotenv.2019.04.208","article-title":"PFOA and PFOS promote diabetic renal injury in vitro by impairing the metabolisms of amino acids and purines","volume":"676","author":"Gong","year":"2019","journal-title":"Sci Total Environ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00244-008-9194-6","article-title":"Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis","volume":"56","author":"Cui","year":"2009","journal-title":"Arch Environ Contam Toxicol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.3390\/ijerph17218020","article-title":"PFAS environmental pollution and antioxidant responses: an overview of the impact on human field","volume":"17","author":"Bonato","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"103667","DOI":"10.1016\/j.etap.2021.103667","article-title":"N-acetyl cysteine abates hepatorenal toxicities induced by perfluorooctanoic acid exposure in male rats","volume":"86","author":"Owumi","year":"2021","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPARalpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfm270","article-title":"Perfluoroalkyl acids and related chemistries\u2014Toxicokinetics and modes of action","volume":"102","author":"Andersen","year":"2008","journal-title":"Toxicol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.reprotox.2011.11.005","article-title":"Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues","volume":"33","author":"Abbott","year":"2012","journal-title":"Reprod Toxicol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/toxsci\/kfl135","article-title":"Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta\/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate","volume":"95","author":"Takacs","year":"2007","journal-title":"Toxicol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fsi.2021.03.004","article-title":"Perfluorooctanoic acid-induced immunotoxicity via NF-kappa B pathway in zebrafish (Danio rerio) kidney","volume":"113","author":"Zhang","year":"2021","journal-title":"Fish Shellfish Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"114422","DOI":"10.1016\/j.ecoenv.2022.114422","article-title":"Aluminum exposure induces nephrotoxicity via fibrosis and apoptosis through the TGF-\u03b21\/Smads pathway in vivo and in vitro","volume":"249","author":"Wei","year":"2023","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"F52","DOI":"10.1152\/ajprenal.00260.2018","article-title":"Macrophage-secreted TGF-\u03b21 contributes to fibroblast activation and ureteral stricture after ablation injury","volume":"317","author":"Ueshima","year":"2019","journal-title":"Am J Physiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/ndt\/gfz177","article-title":"Munc18-1-interacting protein 3 mitigates renal fibrosis through protection of tubular epithelial cells from apoptosis","volume":"35","author":"Nasu","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3390\/cells10113060","article-title":"NSC828779 alleviates renal Tubulointerstitial lesions involving Interleukin-36 signaling in mice","volume":"10","author":"Yang","year":"2021","journal-title":"Cells"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1172\/JCI143645","article-title":"Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-\u03b2 signaling in kidney fibroblasts","volume":"131","author":"Chen","year":"2021","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e04691","DOI":"10.1016\/j.heliyon.2020.e04691","article-title":"Heavy metal pollution in the environment and their toxicological effects on humans","volume":"6","author":"Briffa","year":"2020","journal-title":"Heliyon"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"100565","DOI":"10.1016\/j.gsd.2021.100565","article-title":"Human health hazard assessment for high groundwater arsenic and fluoride intact in Malda district, Eastern India","volume":"13","author":"Sarkar","year":"2021","journal-title":"Groundw Sustain Dev"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.26444\/aaem\/74715","article-title":"The history of arsenical pesticides and health risks related to the use of agent blue","volume":"24","author":"Bencko","year":"2017","journal-title":"Ann Agric Environ Med"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.scitotenv.2015.11.133","article-title":"A comprehensive assessment of arsenic in commonly consumed foodstuffs to evaluate the potential health risk in Bangladesh","volume":"544","author":"Ahmed","year":"2016","journal-title":"Sci Total Environ"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s00424-020-02439-5","article-title":"Glucose transporters in the small intestine in health and disease","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflugers Arch"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/ijms18051039","article-title":"Chronic kidney disease and exposure to nephrotoxic metals","volume":"18","author":"Orr","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1039\/B307945G","article-title":"Arsenic\u2013glutathione complexes\u2014their stability in solution and during separation by different HPLC modes","volume":"19","author":"Raab","year":"2004","journal-title":"J Anal At Spectrom"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.biocel.2013.06.022","article-title":"Multidrug and toxin extrusion proteins (MATE\/SLC47); role in pharmacokinetics","volume":"45","author":"Staud","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0014-4800(91)90039-Z","article-title":"Autometallographic localization of inorganic mercury in the kidneys of rats: effect of unilateral nephrectomy and compensatory renal growth","volume":"54","author":"Zalups","year":"1991","journal-title":"Exp Mol Pathol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jes.2016.10.001","article-title":"Cellular arsenic transport pathways in mammals","volume":"49","author":"Roggenbeck","year":"2016","journal-title":"J Environ Sci (China)"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"Leslie","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/009841097160564","article-title":"Enhanced renal outer medullary uptake of mercury associated with uninephrectomy: implication of a luminal mechanism","volume":"50","author":"Zalups","year":"1997","journal-title":"J Toxicol Environ Health"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"111442","DOI":"10.1016\/j.jenvman.2020.111442","article-title":"Status and environmental management of soil mercury pollution in China: a review","volume":"277","author":"Liu","year":"2021","journal-title":"J Environ Manag"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"125470","DOI":"10.1016\/j.jhazmat.2021.125470","article-title":"Adsorption-improved MoSe(2) nanosheet by heteroatom doping and its application for simultaneous detection and removal of mercury (II)","volume":"413","author":"Long","year":"2021","journal-title":"J Hazard Mater"},{"key":"ref54","first-page":"10","article-title":"Mercury pollution: dangers and treatment","volume-title":"Marine pollution","author":"Fattima Al-Zahra Gabar","year":"2023"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1021\/es404159k","article-title":"Pathways of CH3Hg and hg ingestion in benthic organisms: an enriched isotope approach","volume":"48","author":"Taylor","year":"2014","journal-title":"Environ Sci Technol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0300-483X(93)90213-C","article-title":"Early aspects of the intrarenal distribution of mercury after the intravenous administration of mercuric chloride","volume":"79","author":"Zalups","year":"1993","journal-title":"Toxicology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-4800(90)90070-T","article-title":"Traces of mercury in organs from primates with amalgam fillings","volume":"52","author":"Danscher","year":"1990","journal-title":"Exp Mol Pathol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1124\/mol.63.3.590","article-title":"Human renal organic anion transporter 1-dependent uptake and toxicity of mercuric-thiol conjugates in Madin-Darby canine kidney cells","volume":"63","author":"Aslamkhan","year":"2003","journal-title":"Mol Pharmacol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1111\/j.1523-1755.2005.00585.x","article-title":"Handling of cysteine S-conjugates of methylmercury in MDCK cells expressing human OAT1","volume":"68","author":"Zalups","year":"2005","journal-title":"Kidney Int"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tox.2005.01.006","article-title":"Morphologic and functional alterations induced by low doses of mercuric chloride in the kidney OK cell line: ultrastructural evidence for an apoptotic mechanism of damage","volume":"210","author":"Carranza-Rosales","year":"2005","journal-title":"Toxicology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/toxins10040155","article-title":"The role of Gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease","volume":"10","author":"Koppe","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00424-020-02352-x","article-title":"Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis","volume":"472","author":"Rukavina Mikusic","year":"2020","journal-title":"Pflugers Arch"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"P-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref64","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys","volume":"62","author":"Miyazaki","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s11255-018-1873-2","article-title":"The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus","volume":"50","author":"Kanbay","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"110583","DOI":"10.1016\/j.cellsig.2022.110583","article-title":"Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease","volume":"104","author":"Hamza","year":"2023","journal-title":"Cell Signal"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e108448","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by Indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS One"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41581-018-0018-2","article-title":"The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease","volume":"14","author":"Yang","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1007\/s11255-019-02291-2","article-title":"The gut microbiota and its relationship with chronic kidney disease","volume":"51","author":"Plata","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e001852","DOI":"10.1161\/JAHA.115.001852","article-title":"P-Cresyl sulfate aggravates cardiac dysfunction associated with chronic kidney disease by enhancing apoptosis of cardiomyocytes","volume":"4","author":"Han","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"e34026","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/toxins11110635","article-title":"Elevation of trimethylamine-N-oxide in chronic kidney disease: contribution of decreased glomerular filtration rate","volume":"11","author":"Pelletier","year":"2019","journal-title":"Toxins (Basel)"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"637480","DOI":"10.3389\/fphys.2021.637480","article-title":"DNA methylation sustains \"inflamed\" memory of peripheral immune cells aggravating kidney inflammatory response in chronic kidney disease","volume":"12","author":"Chen","year":"2021","journal-title":"Front Physiol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00441-017-2588-x","article-title":"Epigenetics of kidney disease","volume":"369","author":"Wanner","year":"2017","journal-title":"Cell Tissue Res"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1046\/j.1523-1755.2000.07708.x","article-title":"Smad proteins and transforming growth factor-beta signaling","volume":"58","author":"Schiffer","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1523-1755.2004.00779.x","article-title":"Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction","volume":"66","author":"Inazaki","year":"2004","journal-title":"Kidney Int"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3724\/abbs.2021005","article-title":"miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia","volume":"54","author":"Ding","year":"2022","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","article-title":"Hypoxia as a key player in the AKI-to-CKD transition","volume":"307","author":"Tanaka","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","article-title":"Homeostatic immunity and the microbiota","volume":"46","author":"Belkaid","year":"2017","journal-title":"Immunity"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.3390\/ijms23073954","article-title":"Chronic kidney disease and Gut microbiota: what is their connection in early life?","volume":"23","author":"Hsu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.4049\/jimmunol.176.10.6022","article-title":"Costimulation of chemokine receptor signaling by matrix Metalloproteinase-9 mediates enhanced migration of IFN-\u03b1 dendritic cells","volume":"176","author":"Hu","year":"2006","journal-title":"J Immunol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and Gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1093\/ndt\/gfl273","article-title":"Ssociations between renal function, volume status and endotoxaemia in chronic kidney disease patients","volume":"21","author":"Gon\u00e7alves","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.kint.2017.02.011","article-title":"Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach","volume":"92","author":"Mishima","year":"2017","journal-title":"Kidney Int"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/toxins12080502","article-title":"Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase","volume":"12","author":"Tanaka","year":"2020","journal-title":"Toxins (Basel)"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.tem.2016.08.003","article-title":"Linking the microbiota, chronic disease, and the immune system","volume":"27","author":"Hand","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.3390\/jcm12093107","article-title":"Impact of single hemodialysis treatment on immune cell subpopulations","volume":"12","author":"Donadei","year":"2023","journal-title":"J Clin Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.yexcr.2018.02.022","article-title":"Chronic kidney disease induces inflammation by increasing toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes","volume":"365","author":"Grabulosa","year":"2018","journal-title":"Exp Cell Res"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","article-title":"Protein-bound uremic toxins, inflammation and oxidative stress: a Cross-sectional study in stage 3\u20134 chronic kidney disease","volume":"45","author":"Rossi","year":"2014","journal-title":"Arch Med Res"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/ndt\/gfu287","article-title":"Alterations of intestinal barrier and microbiota in chronic kidney disease","volume":"30","author":"Sabatino","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-immunol-051116-052424","article-title":"Mucosal ecological network of epithelium and immune cells for Gut homeostasis and tissue healing","volume":"35","author":"Kurashima","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/cells11233758","article-title":"NLRP3 and Gut microbiota homeostasis: Progress in research","volume":"11","author":"Lin","year":"2022","journal-title":"Cells"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1080\/10408398.2021.1996331","article-title":"Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: a focus on dietary fibers","volume":"63","author":"Melekoglu","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as cardiovascular risk factor in chronic kidney disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ Res"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","article-title":"The leaky Gut and altered microbiome in chronic kidney disease","volume":"27","author":"Lau","year":"2017","journal-title":"J Ren Nutr"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Ren Physiol"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijms221810084","article-title":"Lin SH: chronic kidney disease: strategies to retard progression","volume":"22","author":"Yan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/ndt\/gfy172","article-title":"Intestinal barrier disruption and dysregulated mucosal immunity contribute to kidney fibrosis in chronic kidney disease","volume":"34","author":"Yang","year":"2019","journal-title":"Nephrol Dial Transplantat"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.4161\/auto.7066","article-title":"Hu C-aA: ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death","volume":"4","author":"Zhaorigetu","year":"2008","journal-title":"Autophagy"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nm.4287","article-title":"Hu C-AA: transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice","volume":"23","author":"Beckerman","year":"2017","journal-title":"Nat Med"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ntr\/ntu016","article-title":"Children's exposure to secondhand and thirdhand smoke carcinogens and toxicants in homes of hookah smokers","volume":"16","author":"Kassem","year":"2014","journal-title":"Nicotine Tob Res"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1021\/es5014533","article-title":"Ambient acrolein concentrations in coastal, remote, and urban regions in California","volume":"48","author":"Cahill","year":"2014","journal-title":"Environ Sci Technol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.200700412","article-title":"Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease","volume":"52","author":"Stevens","year":"2008","journal-title":"Mol Nutr Food Res"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/mnfr.201100481","article-title":"Toxicology and risk assessment of acrolein in food","volume":"55","author":"Abraham","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"16058","DOI":"10.1074\/jbc.273.26.16058","article-title":"Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins","volume":"273","author":"Uchida","year":"1998","journal-title":"J Biol Chem"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0891-5849(93)90058-3","article-title":"Acrolein-induced oxygen radical formation","volume":"15","author":"Adams","year":"1993","journal-title":"Free Radic Biol Med"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.toxlet.2012.06.003","article-title":"\/ prior exposure to acrolein accelerates pulmonary inflammation in influenza A-infected mice","volume":"212","author":"Ong","year":"2012","journal-title":"Toxicol Lett"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-007-9411-z","article-title":"Induction of COX-2 by acrolein in rat lung epithelial cells","volume":"301","author":"Sarkar","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"19666","DOI":"10.1074\/jbc.M611527200","article-title":"Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain","volume":"282","author":"Lambert","year":"2007","journal-title":"J Biol Chem"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/ars.2005.7.25","article-title":"Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein","volume":"7","author":"Valacchi","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbrc.2023.05.029","article-title":"Acrolein produced during acute kidney injury promotes tubular cell death","volume":"666","author":"Aihara","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1530\/EJE-22-0493","article-title":"Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo","volume":"187","author":"Tong","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol Toxicol"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/toxins10090367","article-title":"Impacts of Indoxyl sulfate and p-cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bbrc.2020.02.141","article-title":"Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition","volume":"525","author":"Sato","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.23876\/j.krcp.2017.36.1.68","article-title":"Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin study against renal disease progression in Korea","volume":"36","author":"Cha","year":"2017","journal-title":"Kidney Res Clin Pract"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/jcm8101718","article-title":"Effects and safety of an Oral adsorbent on chronic kidney disease progression: a systematic review and Meta-analysis","volume":"8","author":"Chen","year":"2019","journal-title":"J Clin Med"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nefro.2015.05.022","article-title":"Use of sevelamer in chronic kidney disease: beyond phosphorus control","volume":"35","author":"Rodr\u00edguez-Osorio","year":"2015","journal-title":"Nefrologia"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14728222.2020.1762173","article-title":"New therapeutic targets in chronic kidney disease progression and renal fibrosis","volume":"24","author":"Rayego-Mateos","year":"2020","journal-title":"Expert Opin Ther Targets"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3390\/microorganisms11040980","article-title":"The role of microbiota in upper and lower gastrointestinal functional disorders","volume":"11","author":"Mandarino","year":"2023","journal-title":"Microorganisms"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jfda.2018.12.011","article-title":"Next generation probiotics in disease amelioration","volume":"27","author":"Chang","year":"2019","journal-title":"J Food Drug Anal"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/ijms21072285","article-title":"An updated overview on Nanonutraceuticals: focus on Nanoprebiotics and Nanoprobiotics","volume":"21","author":"Durazzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"919725","DOI":"10.3389\/fmicb.2022.919725","article-title":"The future of Synbiotics: rational formulation and design","volume":"13","author":"Gomez Quintero","year":"2022","journal-title":"Front Microbiol"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/jam.12157","article-title":"Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability","volume":"114","author":"Kalmokoff","year":"2013","journal-title":"J Appl Microbiol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"F857","DOI":"10.1152\/ajprenal.00513.2015","article-title":"Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats","volume":"310","author":"Kieffer","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"e114881","DOI":"10.1371\/journal.pone.0114881","article-title":"High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease","volume":"9","author":"Vaziri","year":"2014","journal-title":"PLoS One"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ki.2011.355","article-title":"High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease","volume":"81","author":"Krishnamurthy","year":"2012","journal-title":"Kidney Int"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/joim.12818","article-title":"Therapeutic value of stimulating the nitrate-nitrite-nitric oxide pathway to attenuate oxidative stress and restore nitric oxide bioavailability in cardiorenal disease","volume":"285","author":"Carlstrom","year":"2019","journal-title":"J Intern Med"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"F1327","DOI":"10.1152\/ajprenal.00272.2019","article-title":"Uric acid and inflammation in kidney disease","volume":"318","author":"Jung","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"285","DOI":"10.14348\/molcells.2015.0010","article-title":"Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease","volume":"38","author":"Gorin","year":"2015","journal-title":"Mol Cells"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"102781","DOI":"10.1016\/j.redox.2023.102781","article-title":"Nox4 as a novel therapeutic target for diabetic vascular complications","volume":"64","author":"Wang","year":"2023","journal-title":"Redox Biol"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","article-title":"Oxidative stress in end-stage renal disease: an emerging threat to patient outcome","volume":"18","author":"Locatelli","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0891-5849(99)00264-6","article-title":"Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo","volume":"28","author":"Roberts","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ekir.2017.11.020","article-title":"Urinary markers of oxidative stress are associated with albuminuria but not GFR decline","volume":"3","author":"Schei","year":"2018","journal-title":"Kidney Int Rep"},{"key":"ref145","year":""},{"key":"ref146","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1681\/ASN.2009020146","article-title":"NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts","volume":"21","author":"Bondi","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2014.287","article-title":"Origin of myofibroblasts and cellular events triggering fibrosis","volume":"87","author":"Mack","year":"2015","journal-title":"Kidney Int"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/ki.2014.386","article-title":"p47(phox) contributes to albuminuria and kidney fibrosis in mice","volume":"87","author":"Wang","year":"2015","journal-title":"Kidney Int"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semnephrol.2004.04.007","article-title":"Nitric oxide, oxidative stress, and progression of chronic renal failure","volume":"24","author":"Modlinger","year":"2004","journal-title":"Semin Nephrol"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/nu14204297","article-title":"Evolving concepts on inflammatory biomarkers and malnutrition in chronic kidney disease","volume":"14","author":"Graterol Torres","year":"2022","journal-title":"Nutrients"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/cells12121581","article-title":"The role of inflammation in CKD","volume":"12","author":"Kadatane","year":"2023","journal-title":"Cells"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/JAMACARDIO.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"27159","DOI":"10.1074\/jbc.M114.567537","article-title":"Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia","volume":"289","author":"Abais","year":"2014","journal-title":"J Biol Chem"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/CJN.10441015","article-title":"Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD","volume":"11","author":"Sun","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/ndt\/gfu233","article-title":"Interleukin-6 in renal disease and therapy","volume":"30","author":"Jones","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","article-title":"Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives","volume":"18","author":"Kreiner","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/BOR.0b013e3283295fec","article-title":"Clinical value of blocking IL-6 receptor","volume":"21","author":"Mima","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/JLB.MR1217-489R","article-title":"The role of IL-20 in chronic kidney disease and diabetic nephropathy: pathogenic and therapeutic implications","volume":"104","author":"Chang","year":"2018","journal-title":"J Leukoc Biol"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/imm.13403","article-title":"IL-20 is involved in obesity by modulation of adipogenesis and macrophage dysregulation","volume":"164","author":"Hsu","year":"2021","journal-title":"Immunology"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/biom10020257","article-title":"Salafutdinov I: proteomic analysis of human serum from patients with chronic kidney disease","volume":"10","author":"Romanova","year":"2020","journal-title":"Biomol Ther"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/MOT.0000000000000313","article-title":"Role of monocytes and macrophages in regulating immune response following lung transplantation","volume":"21","author":"Chiu","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1111\/bph.14427","article-title":"Role of immune cells in hypertension","volume":"176","author":"Caillon","year":"2019","journal-title":"Br J Pharmacol"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1124\/jpet.113.205732","article-title":"NLRP3 Inflammasome knockout mice are protected against ischemic but not cisplatin-induced acute kidney injury","volume":"346","author":"Kim","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/imcb.12236","article-title":"Macrophages in wound healing: activation and plasticity","volume":"97","author":"Kim","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.0105-2896.2005.00260.x","article-title":"Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes","volume":"205","author":"Stout","year":"2005","journal-title":"Immunol Rev"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.kint.2017.09.022","article-title":"The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1\u2013mediated tissue injury","volume":"93","author":"Anders","year":"2018","journal-title":"Kidney Int"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biocel.2014.09.018","article-title":"Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-induced tubulointerstitial inflammation","volume":"57","author":"Liu","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1053\/j.ajkd.2020.05.015","article-title":"Neutrophil gelatinase-associated Lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for Dialysis therapy: a systematic review and Meta-analysis","volume":"76","author":"Albert","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2020.07.011","article-title":"Novel risk factors for progression of diabetic and nondiabetic CKD: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"77","author":"Anderson","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"100695","DOI":"10.1016\/j.ijcha.2020.100695","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention","volume":"32","author":"Banai","year":"2021","journal-title":"IJC Heart Vasc"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/cc10379","article-title":"Neutrophil gelatinase-associated lipocalin as a marker of tubular damage appears to be unrelated to fractional excretion of sodium as a marker of tubular function in septic patients, with or without AKI","volume":"15","author":"Glassford","year":"2011","journal-title":"Crit Care"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00277-021-04500-4","article-title":"Neutrophil gelatinase-associated lipocalin as a biomarker of nephropathy in sickle cell disease","volume":"100","author":"Marouf","year":"2021","journal-title":"Ann Hematol"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/01.mnh.0000232886.81142.58","article-title":"Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia","volume":"15","author":"Schmidt-Ott","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/ki.2008.529","article-title":"Elevated urine neutrophil gelatinase-associated lipocalin can diagnose acute kidney injury in patients with chronic kidney diseases","volume":"75","author":"Sise","year":"2009","journal-title":"Kidney Int"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"e016028","DOI":"10.1136\/bmjopen-2017-016028","article-title":"Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study","volume":"7","author":"Tecson","year":"2017","journal-title":"BMJ"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.yexcr.2008.08.005","article-title":"The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology","volume":"315","author":"Zeng","year":"2009","journal-title":"Exp Cell Res"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1186\/s13054-016-1212-x","article-title":"Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2016","journal-title":"Crit Care"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/ejcts\/ezv199","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis","volume":"49","author":"Zhou","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref182","first-page":"32","article-title":"Comparison of BTP, NGAL, KIM-1, & ADMA biomarkers in CKD and non-CKD subjects","volume":"14","author":"Bansal","year":"2023","journal-title":"Int J Biochem Mol Biol"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biom10010154","article-title":"The Association of Matrix Metalloproteinases with chronic kidney disease and peripheral vascular disease: a light at the end of the tunnel?","volume":"10","author":"Provenzano","year":"2020","journal-title":"Biomol Ther"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-008-9114-6","article-title":"Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy","volume":"35","author":"Thrailkill","year":"2009","journal-title":"Endocrine"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"113565","DOI":"10.1016\/j.biopha.2022.113565","article-title":"Matrix metalloproteinase-7 promotes chronic kidney disease progression via the induction of inflammasomes and the suppression of autophagy","volume":"154","author":"Zheng","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1172\/jci.insight.122399","article-title":"Tubular injury triggers podocyte dysfunction by \u03b2-catenin\u2013driven release of MMP-7. JCI","volume":"4","author":"Tan","year":"2019","journal-title":"Insight"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3390\/biom10060960","article-title":"The many faces of matrix Metalloproteinase-7 in kidney diseases","volume":"10","author":"Liu","year":"2020","journal-title":"Biomol Ther"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1681\/ASN.2016030354","article-title":"Matrix metalloproteinase-7 is a urinary biomarker and pathogenic mediator of kidney fibrosis","volume":"28","author":"Zhou","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom11020194","article-title":"Aortic aneurysms, chronic kidney disease and metalloproteinases","volume":"11","author":"Andreucci","year":"2021","journal-title":"Biomol Ther"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000243050","article-title":"Fibroblast growth factor 23 and matrix-metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease?","volume":"32","author":"Peiskerov\u00e1","year":"2009","journal-title":"Kidney Blood Press Res"},{"key":"ref191","first-page":"99","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in chronic kidney disease and acute kidney injury: a systematic review of the literature","volume":"22","author":"Sampieri","year":"2018","journal-title":"Hippokratia"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.kint.2016.10.020","article-title":"The pattern recognition receptor, Mincle, is essential for maintaining the M1 macrophage phenotype in acute renal inflammation","volume":"91","author":"Lv","year":"2017","journal-title":"Kidney Int"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1177\/0271678X16661201","article-title":"An atypical role for the myeloid receptor Mincle in central nervous system injury","volume":"37","author":"Arumugam","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"1385696","DOI":"10.3389\/fimmu.2024.1385696","article-title":"Mincle receptor in macrophage and neutrophil contributes to the unresolved inflammation during the transition from acute kidney injury to chronic kidney disease","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0891-5849(91)90033-Y","article-title":"Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol","volume":"10","author":"Serbinova","year":"1991","journal-title":"Free Radic Biol Med"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1749-6632.1982.tb31231.x","article-title":"Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E","volume":"393","author":"Machlin","year":"1982","journal-title":"Ann N Y Acad Sci"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1159\/000112413","article-title":"Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease","volume":"28","author":"Karamouzis","year":"2008","journal-title":"Am J Nephrol"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cccn.2003.07.020","article-title":"The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients","volume":"338","author":"Giray","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1440-1681.2007.04651.x","article-title":"Renoprotective effect of trolox against ischaemia\u2013reperfusion injury in rats","volume":"34","author":"Wongmekiat","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1440-1797.2012.01572.x","article-title":"Oxidative stress, anti-oxidant therapies and chronic kidney disease","volume":"17","author":"Small","year":"2012","journal-title":"Nephrology"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/mnfr.201000195","article-title":"The effects of dietary fish oil on inflammation, fibrosis and oxidative stress associated with obstructive renal injury in rats","volume":"55","author":"Peake","year":"2011","journal-title":"Mol Nutr Food Res"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1079\/BJN20051626","article-title":"Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating \u03b3-glutamyl-cysteinyl ligase and glutathione reductase","volume":"95","author":"Arab","year":"2006","journal-title":"Br J Nutr"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000299798","article-title":"Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-\u0138B activation","volume":"31","author":"Tumur","year":"2010","journal-title":"Am J Nephrol"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"c207","DOI":"10.1159\/000317201","article-title":"N-acetylcysteine for the management of anemia and oxidative stress in hemodialysis patients","volume":"116","author":"Hsu","year":"2010","journal-title":"Nephron Clin Pract"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3747\/pdi.2009.00073","article-title":"Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study","volume":"30","author":"Nascimento","year":"2010","journal-title":"Perit Dial Int"},{"key":"ref206","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/bjp.2008.343","article-title":"Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4","volume":"155","author":"El-Sheikh","year":"2008","journal-title":"Br J Pharmacol"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"F481","DOI":"10.1152\/ajprenal.00092.2009","article-title":"Effect of lowering uric acid on renal disease in the type 2 diabetic db\/db mice","volume":"297","author":"Kosugi","year":"2009","journal-title":"Am J Physiol"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0891-5849(98)00330-X","article-title":"Effects of coenzyme Q10 and \u03b1-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial \u03b1-tocopherol by coenzyme Q10","volume":"26","author":"Lass","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1073\/pnas.87.12.4879","article-title":"Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations","volume":"87","author":"Frei","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10157-010-0350-8","article-title":"Renal preservation effect of ubiquinol, the reduced form of coenzyme Q10","volume":"15","author":"Ishikawa","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-020-02177-x","article-title":"The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper","volume":"21","author":"Headley","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1038\/ki.2010.418","article-title":"Mechanistic connection between inflammation and fibrosis","volume":"78","author":"Lee","year":"2010","journal-title":"Kidney Int"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/sj.ki.5001775","article-title":"IN-1130, a novel transforming growth factor-\u03b2 type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy","volume":"70","author":"Moon","year":"2006","journal-title":"Kidney Int"},{"key":"ref214","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"ref215","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"ref216","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"ref217","doi-asserted-by":"publisher","first-page":"F326","DOI":"10.1152\/ajprenal.00647.2013","article-title":"APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability","volume":"307","author":"Lan","year":"2014","journal-title":"Am J Physiol"},{"key":"ref218","doi-asserted-by":"publisher","first-page":"e51185","DOI":"10.7554\/eLife.51185","article-title":"Apolipoprotein L-1 renal risk variants form active channels at the plasma membrane driving cytotoxicity","volume":"9","author":"Giovinazzo","year":"2020","journal-title":"eLife"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2215\/CJN.01180117","article-title":"APOL1 risk variants, incident proteinuria, and subsequent eGFR decline in blacks with hypertension-attributed CKD","volume":"12","author":"Chen","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref220","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1681\/ASN.2010070730","article-title":"The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans","volume":"21","author":"Freedman","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref221","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MNH.0b013e3283600f8c","article-title":"Rethinking hypertensive kidney disease: arterionephrosclerosis as a genetic, metabolic, and inflammatory disorder","volume":"22","author":"Kopp","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref222","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.kint.2021.07.015","article-title":"A multi-center retrospective cohort study defines the spectrum of kidney pathology in coronavirus 2019 disease (COVID-19)","volume":"100","author":"May","year":"2021","journal-title":"Kidney Int"},{"key":"ref223","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1073\/pnas.1421953112","article-title":"Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis","volume":"112","author":"Thomson","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.molbiopara.2005.08.018","article-title":"Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes","volume":"144","author":"Molina-Portela Mdel","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"ref225","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0014-4894(84)90023-7","article-title":"Trypanosoma brucei: biochemical and morphological studies of cytotoxicity caused by normal human serum","volume":"58","author":"Rifkin","year":"1984","journal-title":"Exp Parasitol"},{"key":"ref226","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1681\/ASN.2020010079","article-title":"Kidney disease-associated APOL1 variants have dose-dependent, dominant toxic gain-of-function","volume":"31","author":"Datta","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"ref227","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1681\/ASN.2016050567","article-title":"APOL1 renal-risk variants induce mitochondrial dysfunction","volume":"28","author":"Ma","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"ref228","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1681\/ASN.2016111220","article-title":"Intracellular APOL1 risk variants cause cytotoxicity accompanied by energy depletion","volume":"28","author":"Granado","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"ref229","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ndt\/gfu391","article-title":"APOL1 nephropathy: from gene to mechanisms of kidney injury","volume":"31","author":"Kruzel-Davila","year":"2015","journal-title":"Nephrol Dial Transplantat"},{"key":"ref230","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jfma.2018.03.017","article-title":"Physiology and pathophysiology of renal erythropoietin-producing cells","volume":"117","author":"Shih","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"ref231","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood.V73.1.13.13","article-title":"Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure","volume":"73","author":"Schuster","year":"1989","journal-title":"Blood"},{"key":"ref232","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1128\/MCB.6.7.2731","article-title":"Anemia induces accumulation of erythropoietin mRNA in the kidney and liver","volume":"6","author":"Bondurant","year":"1986","journal-title":"Mol Cell Biol"},{"key":"ref233","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jfms.2011.07.016","article-title":"Anemia of renal disease: what it is, what to do and what's new","volume":"13","author":"Chalhoub","year":"2011","journal-title":"J Feline Med Surg"},{"key":"ref234","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0889-8588(18)30134-5","article-title":"Regulation of erythropoietin production. New insights into molecular mechanisms of oxygen homeostasis","volume":"8","author":"Semenza","year":"1994","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref235","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ki.1997.77","article-title":"Structural and functional analysis of hypoxia-inducible factor 1","volume":"51","author":"Semenza","year":"1997","journal-title":"Kidney Int"},{"key":"ref236","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0034-5687(99)00024-9","article-title":"Oxygen sensing and signaling: impact on the regulation of physiologically important genes","volume":"115","author":"Zhu","year":"1999","journal-title":"Respir Physiol"},{"key":"ref237","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/ijms222212590","article-title":"Hypoxia-inducible factor stabilizers in end stage kidney disease: \"can the promise be kept?\"","volume":"22","author":"Crugliano","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref238","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fmed.2020.00047","article-title":"Advances in understanding the effects of erythropoietin on renal fibrosis","volume":"7","author":"Zhang","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"ref239","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.ekir.2021.05.028","article-title":"Treatment of Anemia in kidney disease: beyond erythropoietin","volume":"6","author":"Wish","year":"2021","journal-title":"Kidney Int Rep"},{"key":"ref240","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000463063","article-title":"Polycystic kidney disease and the vasopressin pathway","volume":"70","author":"van Gastel","year":"2017","journal-title":"Ann Nutr Metab"},{"key":"ref241","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/ckj\/sfu050","article-title":"Central vasopressin: dendritic and axonal secretion and renal actions","volume":"7","author":"Bichet","year":"2014","journal-title":"Clin Kidney J"},{"key":"ref242","author":"Brodney","year":"2020"},{"key":"ref243","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1172\/JCI172262","article-title":"APOL1-mediated monovalent cation transport contributes to APOL1-mediated podocytopathy in kidney disease","volume":"134","author":"Datta","year":"2024","journal-title":"J Clin Invest"},{"key":"ref244","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJMoa2202396","article-title":"Inaxaplin for Proteinuric kidney disease in persons with two APOL1 variants","volume":"388","author":"Egbuna","year":"2023","journal-title":"N Engl J Med"},{"key":"ref245","article-title":"Anemia of chronic renal disease","volume-title":"StatPearls","author":"Shaikh","year":"2024"},{"key":"ref246","first-page":"381","article-title":"Erythropoietin: current status","volume":"63","author":"Bunn","year":"1990","journal-title":"Yale J Biol Med"},{"key":"ref247","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2169\/internalmedicine.43.649","article-title":"Molecular biology of erythropoietin","volume":"43","author":"Jelkmann","year":"2004","journal-title":"Intern Med"},{"key":"ref248","doi-asserted-by":"publisher","first-page":"e10358","DOI":"10.7759\/cureus.10358","article-title":"Erythropoietin Administration for Anemia due to chronic kidney disease - subcutaneous OR intravenous, what do we know so far?","volume":"12","author":"Shahab","year":"2020","journal-title":"Cureus"},{"key":"ref249","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.kisu.2020.12.002","article-title":"Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease","volume":"11","author":"Haase","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"ref250","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.ackd.2019.04.004","article-title":"Hypoxia-inducible factor activators in renal Anemia: current clinical experience","volume":"26","author":"Sanghani","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref251","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s41100-020-00311-x","article-title":"A new insight into the treatment of renal anemia with HIF stabilizer","volume":"6","author":"Kuriyama","year":"2020","journal-title":"Ren Replac Ther"},{"key":"ref252","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/ckj\/sfac271","article-title":"The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis","volume":"16","author":"Takkavatakarn","year":"2023","journal-title":"Clin Kidney J"},{"key":"ref253","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref254","author":"Furlano","year":"2023"},{"key":"ref255","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3390\/ijms18051083","article-title":"SGLT2 inhibitors as a therapeutic option for diabetic nephropathy","volume":"18","author":"Kawanami","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref256","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.3390\/cells10092497","article-title":"Autophagy dysregulation in diabetic kidney disease: from pathophysiology to pharmacological interventions","volume":"10","author":"Gonzalez","year":"2021","journal-title":"Cells"},{"key":"ref257","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1172\/JCI167700","article-title":"Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors","volume":"133","author":"Tuttle","year":"2023","journal-title":"J Clin Invest"},{"key":"ref258","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1681\/ASN.2020010010","article-title":"Role of impaired nutrient and oxygen deprivation signaling and deficient autophagic flux in diabetic CKD development: implications for understanding the effects of sodium-glucose cotransporter 2-inhibitors","volume":"31","author":"Packer","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"ref259","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dci19-0074","article-title":"SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action","volume":"43","author":"Packer","year":"2020","journal-title":"Diabetes Care"},{"key":"ref260","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J Clin Invest"},{"key":"ref261","doi-asserted-by":"publisher","first-page":"107954","DOI":"10.1016\/j.celrep.2020.107954","article-title":"Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors","volume":"32","author":"Kogot-Levin","year":"2020","journal-title":"Cell Rep"},{"key":"ref262","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref263","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and-independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"key":"ref264","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41420-021-00801-9","article-title":"Canagliflozin protects against cisplatin-induced acute kidney injury by AMPK-mediated autophagy in renal proximal tubular cells","volume":"8","author":"Park","year":"2022","journal-title":"Cell Death Discov"},{"key":"ref265","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/cells10061457","article-title":"Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells","volume":"10","author":"Xu","year":"2021","journal-title":"Cells"},{"key":"ref266","doi-asserted-by":"publisher","first-page":"154334","DOI":"10.1016\/j.metabol.2020.154334","article-title":"Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway","volume":"111","author":"Liu","year":"2020","journal-title":"Metabolism"},{"key":"ref267","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1126\/science.1101731","article-title":"Nutrient availability regulates SIRT1 through a forkhead-dependent pathway","volume":"306","author":"Nemoto","year":"2004","journal-title":"Science"},{"key":"ref268","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ijbiomac.2018.05.174","article-title":"SIRT1 reverses senescence via enhancing autophagy and attenuates oxidative stress-induced apoptosis through promoting p53 degradation","volume":"117","author":"Liu","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"ref269","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: a long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref270","doi-asserted-by":"publisher","first-page":"e9199","DOI":"10.1371\/journal.pone.0009199","article-title":"SIRT1 negatively regulates the mammalian target of rapamycin","volume":"5","author":"Ghosh","year":"2010","journal-title":"PLoS One"},{"key":"ref271","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1002\/jcp.27306","article-title":"Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1\/PGC-1\u03b1 mediated attenuation of mitochondrial oxidative stress","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"ref272","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11010-020-03686-x","article-title":"Inhibition of tumor necrosis factor-\u03b1 enhanced the antifibrotic effect of empagliflozin in an animal model with renal insulin resistance","volume":"466","author":"Mohamed","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"ref273","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1038\/s41598-018-25054-y","article-title":"High basolateral glucose increases sodium-glucose cotransporter 2 and reduces sirtuin-1 in renal tubules through glucose transporter-2 detection","volume":"8","author":"Umino","year":"2018","journal-title":"Sci Rep"},{"key":"ref274","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1053\/j.ajkd.2020.04.016","article-title":"Mechanisms leading to differential hypoxia-inducible factor signaling in the diabetic kidney: modulation by SGLT2 inhibitors and hypoxia mimetics","volume":"77","author":"Packer","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"ref275","doi-asserted-by":"publisher","first-page":"14754","DOI":"10.1038\/s41598-019-51343-1","article-title":"Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","volume":"9","author":"Bessho","year":"2019","journal-title":"Sci Rep"},{"key":"ref276","doi-asserted-by":"publisher","first-page":"30800","DOI":"10.1074\/jbc.M111.244780","article-title":"The acetylase\/deacetylase couple CREB-binding protein\/Sirtuin 1 controls hypoxia-inducible factor 2 signaling","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"key":"ref277","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/jci.insight.98720","article-title":"SGLT2 inhibitor dapagliflozin limits podocyte damage in proteinuric nondiabetic nephropathy","volume":"3","author":"Cassis","year":"2018","journal-title":"JCI Insight"},{"key":"ref278","doi-asserted-by":"publisher","first-page":"C661","DOI":"10.1152\/ajpcell.00177.2023","article-title":"Reno-and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench","volume":"325","author":"Chen","year":"2023","journal-title":"Am J Phys Cell Phys"},{"key":"ref279","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.34067\/KID.0000000000000268","article-title":"Nrf2 activation in the glomeruli and podocytes: deciphering the renal mechanisms of Nrf2","volume":"4","author":"Lopez-Ruiz","year":"2023","journal-title":"Kidney360"},{"key":"ref280","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.ekir.2022.04.094","article-title":"Prescribing SGLT2 inhibitors in patients with CKD: expanding indications and practical considerations","volume":"7","author":"Yau","year":"2022","journal-title":"Kidney Int Rep"},{"key":"ref281","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S2213-8587(20)30369-7","article-title":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","volume":"9","author":"Wheeler","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref282","doi-asserted-by":"publisher","first-page":"e1056","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses Hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref283","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1038\/s41598-023-42989-z","article-title":"SGLT-2 inhibitors improve cardiovascular and renal outcomes in patients with CKD: a systematic review and meta-analysis","volume":"13","author":"Mavrakanas","year":"2023","journal-title":"Sci Rep"},{"key":"ref284","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"key":"ref285","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1526090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T01:58:38Z","timestamp":1739498318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1526090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":285,"alternative-id":["10.3389\/fmed.2025.1526090"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1526090","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"article-number":"1526090"}}